| Previous Close | 0.0500 |
| Open | 0.0450 |
| Bid | 0.0400 x N/A |
| Ask | 0.0450 x N/A |
| Day's Range | 0.0400 - 0.0450 |
| 52 Week Range | 0.0200 - 0.2100 |
| Volume | 270,125 |
| Avg. Volume | 216,375 |
| Market Cap | 7.327M |
| Beta (5Y Monthly) | -13.75 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0200 |
| Earnings Date | Feb. 28, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
COVID19 UPDATE – Lattice Biologics Announces Cessation of Patient Recruitment
Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) ("Lattice Biologics" or the "Company") announces cessation of patient recruitment for its Phase 1 study.
- Business Wire
Lattice Biologics Ltd. Reports Q3 2020 Results
Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) ("Lattice Biologics" or the "Company") announces financial results for Q3 2020.
- Business Wire
Lattice Biologics Issues Shares and Warrants
Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) ("Lattice Biologics" or the "Company") has issued common shares and warrants pursuant to a litigation settlement.
© 2020 Verizon Media. All rights reserved.
